For the year ending 2025-12-31, EXAS has $5,860,629K in assets. $3,459,577K in debts. $955,996K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 955,996 | |||
| Marketable securities | 8,715 | |||
| Accounts receivable, net | 298,653 | |||
| Inventory | 166,201 | |||
| Prepaid expenses and other current assets | 126,284 | |||
| Total current assets | 1,555,849 | |||
| Property, plant and equipment, net | 708,664 | |||
| Operating lease right-of-use assets | 122,332 | |||
| Goodwill | 2,368,048 | |||
| Finite-lived intangible assets, net | 499,925 | |||
| In-process research and development | 420,000 | |||
| Intangible assets, net | 919,925 | |||
| Other long-term assets, net | 185,811 | |||
| Total assets | 5,860,629 | |||
| Accounts payable | 175,868 | |||
| Accrued liabilities | 416,473 | |||
| Operating lease liabilities, current portion | 33,591 | |||
| Convertible notes payable, current | 0 | |||
| Other current liabilities | 15,220 | |||
| Total current liabilities | 641,152 | |||
| Convertible notes, net, less current portion | 2,327,177 | |||
| Other long-term liabilities | 329,317 | |||
| Operating lease liabilities, less current portion | 161,931 | |||
| Total liabilities | 3,459,577 | |||
| Common stock, 0.01 par value authorized400,000,000 shares issued and outstanding190,802,322 and 185,616,438 shares at december31, 2025 and december31, 2024 | 1,909 | |||
| Additional paid-in capital | 7,102,766 | |||
| Accumulated other comprehensive income (loss) | 2,358 | |||
| Accumulated deficit | -4,705,981 | |||
| Total stockholders equity | 2,401,052 | |||
| Total liabilities and stockholders equity | 5,860,629 | |||
EXACT SCIENCES CORP (EXAS)
EXACT SCIENCES CORP (EXAS)